placeholder image

L. L. Ross All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study
  • Contact

    full name

  • L. L. Ross
  • Quick Info

    Publications

    Collaboration